March 28, 2012 – Industry members needing another reason to join the fray of companies participating in the Digital Advertising Alliance’s (DAA’s) voluntary consumer privacy protection program got a big one this week: The Federal Trade Commission’s (FTC’s) final report on protecting consumer privacy. In the report, the FTC recommends that companies begin adopting its […]
Read moreTag: legislation
legislationFDA Draft Guidance on DTC TV Ads Identifies Campaigns Subject to 45-day Pre-Review Process
March 13, 2012 – Draft guidance released today by the FDA – “Guidance for Industry Direct-to-Consumer Television Advertisements” – calls for drug sponsors to submit nearly all direct-to-consumer (DTC) television ads for review 45 days prior to dissemination and specifies the documentations needed for all new advertising claims. The draft guidance describes the full array of […]
Read moreCHC, Other Industry Leaders Warn Congress That New Laws Could Thwart Progress of Voluntary Privacy Programs
March 8, 2012 – Fifteen trade associations – including the Coalition for Healthcare Communication – sent a letter to Congressional leaders this week asking them to hold off on pursuing consumer privacy legislation while industry-led self-regulatory program efforts take hold. Because these efforts are an efficient and effective way to protect consumer privacy interests, the […]
Read moreHouse Health Subcommittee PDUFA V Hearing Yields Little Talk of Marketing – For Now
Feb. 2, 2012 – More than four hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health — and members’ follow-up — nearly exhausted the issues related to the Prescription Drug User Fee Act V (PDUFA V) legislation yesterday, but just one question focused on drug marketing. “It has taken hard work so far […]
Read moreFinally, CMS Issues Sunshine Act Proposed Rule and Resets Compliance Deadlines
Dec. 15, 2011 – The Centers for Medicare & Medicaid Services (CMS) issued its long-awaited Proposed Rule for implementing the Physician Payments Sunshine Act yesterday, just a day before the Senate Special Committee on Aging was slated to hold a hearing about the need for the “timely release of regulations” and the impact on industry […]
Read moreMMM Previews Pharma Debates in DC: Prepare for a Wild Ride in 2012
Dec. 12, 2011 — Facing a need to decrease spending and boost revenues, the federal government will continue to target the pharmaceutical industry in 2012, according to a recent report in the December issue of Medical Marketing & Media. In the report, “Outlook 2012: Detailing DC,” author Matthew Arnold states that although pharma is fighting back, […]
Read moreCMPI Hosting Panel to Discuss PDUFA Without Politics
Nov. 22, 2011 – The Center for Medicine in the Public Interest (CMPI) believes that if politics takes priority over the public health during negotiations for the reauthorization of the Prescription Drug User Fee Act V (PDUFA V), “bad things” will happen. To prevent that outcome, CMPI is leading a panel discussion, entitled “Defining the Future […]
Read moreCMS Misses Sunshine Act Rule Deadline
Oct. 4, 2011 — According to a recent article posted today on the Policy and Medicine Web site, the authors of the Physician Payments Sunshine Act — Sens. Charles Grassley (R-Iowa) and Herb Kohl (D-Wis.) — have sent a letter to Centers for Medicare and Medicaid Services Administrator Donald Berwick expressing their “severe disappointment” that proposed regulations to […]
Read morePitts: BIO’s Call for Drastic Regulatory Change Is On Point
Pitts: BIO’s Call for Drastic Regulatory Change Is On Point June 27, 2011 — In a recent blog entry on DrugWonks.com, Peter Pitts commended BIO’s proposals to revamp the U.S. regulatory system for new treatments and therapies. Pitts mentions that BIO’s plans, as reported in BioCentury, include a progressive approval pathway for unmet condition therapies, […]
Read moreDo Not Track: Coming Soon to a Mobile Device Near You?
May 27, 2011 — As Congress considers six pieces of pending legislation introduced to protect consumers’ privacy online – all but one of which recommends mandatory “Do Not Track” provisions – the Senate Committee on Commerce, Science & Transportation last week held a hearing to discuss whether Do Today saw a good website Not Track […]
Read more